Hovione signs the COP26 manifest to stop climate changes
BCSD Portugal, 23 July 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
BCSD Portugal, 23 July 2021
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Commitment to partnership and joint innovation for cell and gene therapies
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
Outsourced Pharma, April 2023
Investment More Than Doubles Capacity for Spray Drying, a Critical Solubility Enhancement Technology That Could Benefit the Development of 70% of Drugs*